Per yesterday's Conference Transcript - Gary opened his statement with this:
Gary Rabin: We have treated seven patients and all seven of the patients have told us that they have significant changes in their vision
Minn, can you show us where Maurie Hill has said she has shown improvement in her vision, because that would be big
No, Keep, I can't. The reason I posted the info about the 7 mentioned by Gary is because "Karen" said only two patients had shown any improvement. Your point?
Preferably we need third-party validation with lots of data to back up the vision changes. Affirmation of these general comments by GR and others will be a major milestone, and the PPS will adjust accordingly.
Well, the ONE biggie that we are all watching has NOT reported any visual improvement, Maurie Hill. At least not yet and it's been 5 months for her with the 100K transplantation. ACTC has been in hot water before for overstating certain results and I hope they temper those type of statements in order to keep a degree of respect among their peers and among potential investors etc.
"Significant changes" is nebulous. I had "significant changes" to my vision and they were not good. I know we are all chomping at the bit waiting for good news but don't make a mountain out of a mole hill just yet. I'm sure if they had experienced "improved visual acuity", THAT'S what would have been stated. I know there is some #$%$ on here that give thumbs down to everything I say on here, and to him I say "I'm glad you find me relevant". I get a raging hard muscle for every thumb's down you give me. BOING !!!! LOL.
"Gary Rabin: We have treated seven patients and all seven of the patients have told us that they have significant changes in their vision"
I don't believe that:
1. actc has treated more than seven patients
2. The slides only talk about the initial two ladies who had mixed results, and the Brit smd patient.
3. Maurie Hill, the first 100K injection, reported, repeatedly via her blog, no improvement
Minnesota, you're not one to hype actc, what's up?
It's good that Gary said that, but the FDA has not approved anything yet, so it's just subjective evidence for now. Remember we've had all this great news lately, and no bad news, yet the share price remains grossly low, why is that? And it's because no one yet believes enough in ACT to put big money down on them, and by no one I mean institutional investors and big pharma.